Filing Details

Accession Number:
0001447387-11-000048
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-05 15:33:47
Reporting Period:
2011-06-21
Filing Date:
2011-10-05
Accepted Time:
2011-10-05 15:33:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088206 Quick-Med Technologies Inc QMDT Surgical & Medical Instruments & Apparatus (3841) 650797243
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
937074 P L Partners Phronesis 130 East Chestnut Street
Suite 403
Columbus OH 43215
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2011-06-21 3,094 $0.40 6,662,699 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2011-06-21 0 $0.00 6,662,699 No 4 S Indirect By Phronesis Partners, L.P.
Common Stock, Par Value $0.0001 Per Share Disposition 2011-06-22 21,906 $0.40 6,640,793 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2011-06-22 0 $0.00 6,640,793 No 4 S Indirect By Phronesis Partners, L.P.
Common Stock, Par Value $0.0001 Per Share Disposition 2011-06-30 100 $0.40 6,640,693 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2011-06-30 0 $0.00 6,640,693 No 4 S Indirect By Phronesis Partners, L.P.
Common Stock, Par Value $0.0001 Per Share Disposition 2011-07-19 6,000 $0.40 6,634,693 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2011-07-19 0 $0.00 6,634,693 No 4 S Indirect By Phronesis Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Phronesis Partners, L.P.
No 4 S Direct
No 4 S Indirect By Phronesis Partners, L.P.
No 4 S Direct
No 4 S Indirect By Phronesis Partners, L.P.
No 4 S Direct
No 4 S Indirect By Phronesis Partners, L.P.
Footnotes
  1. These securities are owned by Phronesis Partners, L.P., which is a Reporting Person.
  2. These securities may be deemed to be beneficially owned by James E. Wiggins, the general partner of Phronesis Partners, L.P.